CognitiveIn Clinical Trials
ARA-290
Cibinetide
An 11-amino acid peptide derived from erythropoietin (EPO) that selectively activates the innate repair receptor. No erythropoietic effects.
Clinical Trials4 mg daily
Peptide Database
Browse Research Peptides
Comprehensive profiles for 105+ peptides — dosing protocols, mechanisms of action, clinical research, and safety data.
105
Peptides
9
Categories
9 peptides match your filters
CognitiveNot FDA Approved
Cerebrolysin
FPE 1070
A neuropeptide mixture derived from porcine brain tissue, indicated for neurological conditions including stroke recovery, cognitive decline, and traumatic brain injury.
Clinical Trials5-10 mL IV/IM daily for 10-20 days
CognitivePreclinical
Dihexa
N-hexanoic-Tyr-Ile-(6) aminohexanoic amide
A potent cognitive-enhancing peptide derived from angiotensin IV. Reported to be 10 million times more potent than BDNF at promoting synaptogenesis.
Animal Studies5-20 mg oral or sublingual daily
CognitiveNot FDA Approved
GB-115
Ranquilon
A dipeptide anxiolytic and nootropic that acts as a CCK-1 (cholecystokinin) receptor antagonist. Effects noted by day 7.
Clinical Trials6 mg daily (2 mg three times daily)
CognitiveNot FDA Approved
Normoftal
Eye Peptide Bioregulator
Synthesized Khavinson peptide bioregulator containing short peptides (2-4 amino acids) derived from retinal tissue. 1,500 patients treated from 1995-2010 with 95% showing improved visual functions.
Clinical Trials20-40 mg daily (therapy); 20 mg daily (prevention)
CognitivePreclinical
P21
P021
A synthetic peptide mimetic of CNTF (ciliary neurotrophic factor) designed for neurodegenerative disease. Promotes neurogenesis and reduces neuroinflammation.
Animal Studies10-15 mg daily
CognitivePreclinical
PE-22-28
PE22-28
A synthetic heptapeptide (7 amino acids) derived from Spadin, a naturally occurring antidepressant peptide, with enhanced stability.
Animal Studies100-300 mcg intranasal or subcutaneous
CognitiveNot FDA Approved
Selank
Selanc
A synthetic peptide derived from tuftsin, an immunomodulatory peptide. Approved in Russia for anxiety and nootropic effects.
Clinical Trials250-500 mcg intranasal 2-3x daily
CognitiveNot FDA Approved
Semax
SEMAX
Synthetic peptide derived from ACTH (4-10) fragment with added Pro-Gly-Pro sequence. Used clinically in Russia for stroke, traumatic brain injury, and cognitive disorders.
Clinical Trials200-600 mcg intranasal daily